Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
1don MSN
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Before launching the Zepbound vials in 2024, Eli Lilly offered the drug only in a single-dose injector pen, used once weekly, in doses ranging from 2.5 mg to 15 mg. “We launched the vials last ...
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. “It’s about the size of a small city,” says David Ricks, Eli Lilly’s CEO. That’s about 10% ...
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, ...
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their insurance. Novo Nordisk is... Consumers can buy Zepbound and Wegovy direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback